Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer-Reference-Cited by-同舟云学术

Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer

Published:2015-05-27 Issue:1 Volume:152 Page:57-65
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Rocca Andrea,Farolfi Alberto,Maltoni Roberta,Carretta Elisa,Melegari Elisabetta,Ferrario Cristiano,Cecconetto Lorenzo,Sarti Samanta,Schirone Alessio,Fedeli Anna,Andreis Daniele,Pietri Elisabetta,Ibrahim Toni,Montalto Erika,Amadori Dino

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-015-3423-2/fulltext.html

Reference25 articles.

1. Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen C, Van’t Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E (2014) ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Breast 23:489–502. doi: 10.1016/j.breast.2014.08.009

2. Gibson L, Lawrence D, Bliss J (2009) Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. Cochrane Database Syst Rev 4:CD003370. doi: 10.1002/14651858.CD003370

3. Cheang MCU, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, Perou CM, Ellis MJ, Nielsen TO (2009) Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 101:736–750. doi: 10.1093/jnci/djp082

4. Prat A, Cheang MC, Martín M, Parker JS, Carrasco E, Caballero R, Tyldesley S, Gelmon K, Bernard PS, Nielsen TO, Perou CM (2013) Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer. J Clin Oncol 31:203–209. doi: 10.1200/JCO.2012.43.4134

5. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn HJ, Panel members (2011) Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22:1736–1747. doi: 10.1093/annonc/mdr304

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line therapy;BMC Cancer;2024-07-17

2. Predictive Value of Progesterone Receptor in Advanced Stage Breast Cancer Patients Treated with CDK4/6 Inhibitors;2024-04-29

3. Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden;BMC Cancer;2022-09-22

4. Evaluating the Response of Palbociclib on Progression-Free Survival in Hormone Receptor-Positive Metastatic Breast Cancer;Oncology;2022

5. Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study;Annals of Translational Medicine;2021-04